Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anna-Maria Wiesinger"'
Autor:
Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B. Lagler
Publikováno v:
Pharmaceutics, Vol 15, Iss 11, p 2596 (2023)
The journal retracts the article, An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis [...]
Externí odkaz:
https://doaj.org/article/3a5b6b32ed934545a16eb5d3105323dc
Autor:
Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B. Lagler
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1565 (2023)
Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need. Immunomodulatory drugs could be a relevant treatment approach for MPS patients, although they are not lice
Externí odkaz:
https://doaj.org/article/ce18867491c44ecf925bee1148e86ed2
Autor:
Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Maurizio Scarpa, Tobias Moser, Christina Lampe, Christoph Kampmann, Florian B. Lagler
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Mucopolysaccharidoses (MPS) are a group of lysosomal storage diseases (LSDs), characterized by the accumulation of glycosaminoglycans (GAGs). GAG storage-induced inflammatory processes are a driver of cytopathology in MPS and pharmacological immunomo
Externí odkaz:
https://doaj.org/article/17d0f6059bf443e7be55a0d2cb273606
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 416 (2023)
Mucopolysaccharidoses (MPS) are a group of rare, heterogeneous, lysosomal storage disorders. Patients show a broad spectrum of clinical features with a substantial unmet medical need. Individual treatment trials (ITTs) might be a valid, time- and cos
Externí odkaz:
https://doaj.org/article/ebb2326dd0ea44eea5924a443f411732
Autor:
Anna-Maria Wiesinger, Brian Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B. Lagler
Publikováno v:
Pharmaceutics; Volume 15; Issue 5; Pages: 1565
Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need. Immunomodulatory drugs could be a relevant treatment approach for MPS patients, although they are not lice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7bc1ab12312ef9af8aa9fade098ca4
Autor:
Anna-Maria Wiesinger, Florian Lagler, Brian Bigger, Christoph Kampmann, Roberto Giugliani, Maurizio Scarpa
Publikováno v:
Archives of Disease in Childhood. 108:A6.3-A7
IntroductionMucopolysaccharidoses (MPS) are a group of rare lysosomal storage diseases caused by different enzyme deficiencies that lead to accumulation of glycosaminoglycans (GAGs) in lysosomes and the extracellular matrix. This storage-induced infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::523ba33727f6d09eb4e4d5d59bc2ae39
https://doi.org/10.1136/archdischild-2023-esdppp.19
https://doi.org/10.1136/archdischild-2023-esdppp.19
Autor:
Anna-Maria Wiesinger, Florian Lagler, Maurizio Scarpa, Roberto Giugliani, Christina Lampe, Christoph Kampmann
Publikováno v:
Archives of Disease in Childhood. 108:A10.2-A10
IntroductionMucopolysaccharidoses (MPS), comprise a group of rare chronically debilitating metabolic diseases and associated with reduced life expectancy and a substantial unmet clinical need. Current research directs towards a number of new treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87d51bf7acd9759492da1671a8f0f5af
https://doi.org/10.1136/archdischild-2023-esdppp.30
https://doi.org/10.1136/archdischild-2023-esdppp.30
Autor:
Anna-Maria Wiesinger, Brian Bigger, Christina Lampe, Roberto Giugliani, Christoph Kampmann, Tobias Moser, Maurizio Scarpa, Florian B. Lagler
Publikováno v:
Molecular Genetics and Metabolism. 138:107358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fef3e3a7fcebca749eaeb52f1d8d7b7
https://doi.org/10.1016/j.ymgme.2022.107358
https://doi.org/10.1016/j.ymgme.2022.107358
Publikováno v:
Molecular Genetics and Metabolism. 138:107192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa0da17910007e6880938645a34f953b
https://doi.org/10.1016/j.ymgme.2022.107192
https://doi.org/10.1016/j.ymgme.2022.107192
Publikováno v:
Molecular Genetics and Metabolism. 138:107359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0b05acba4ca09540f6c14337e7c41f5
https://doi.org/10.1016/j.ymgme.2022.107359
https://doi.org/10.1016/j.ymgme.2022.107359